Skip to main content

Table 1 Clinical information statistics of training set and validation set samples

From: Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma

Characteristic

GSE102073 training datasets (n = 85)

TCGA test datasets (n = 371)

GSE26712 validation set (n = 185)

Age

  ≤ 50

62

283

NA

  > 50

11

75

NA

Stage

 Stage III

49

285

NA

 Stage IV

20

53

NA

 Other

4

20

NA

Survival status

 Live

17

160

24

 Dead

56

189

129